Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Триметазидин (обзор последних зарубежных публикаций)
Триметазидин (обзор последних зарубежных публикаций)
Акатова Е.В. Триметазидин (обзор последних зарубежных публикаций). Consilium Medicum. 2018; 20 (10): 53–58. DOI: 10.26442/2075-1753_2018.10.53-58
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Обзор последних данных рандомизированных исследований, метаанализов и экспериментальных работ, доказывающих эффективность применения триметазидина при сердечно-сосудистых заболеваниях и коморбидной патологии.
Ключевые слова: триметазидин, ишемическая болезнь сердца, хроническая сердечная недостаточность.
Ключевые слова: триметазидин, ишемическая болезнь сердца, хроническая сердечная недостаточность.
________________________________________________
Review of the latest data of randomized studies, meta-analyses and experimental studies proving the effectiveness of trimetazidine in cardiovascular diseases and comorbid pathology.
Key words: trimetazidine, coronary heart disease, congestive heart failure.
Key words: trimetazidine, coronary heart disease, congestive heart failure.
Полный текст
Список литературы
1. Tritto I, Wang Pe, Kuppusamy P. The Anti-Anginal Drug Trimetazidine Reduces Neutrophil-Mediated Cardiac Reperfusion Injury. Cardiovasc Pharmacol 2015; 46 (1): 89–98.
2. Jeong Su Kim, Chang Hoon Kim, Kook Jin Chun. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry. Clin Res Cardiol. DOI 10.1007/s00392-013-0611-03. Szwed H, Sadowski Z, Elikowski W. Combination treatment in stable effort angina using trimetazidine and metoprolol Results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J 2011; 22: 2267–74.
4. Song Peng, Min Zhao, Jing Wan. The efficacy of trimetazidine on stable angina pectoris: A meta-analysis of randomized clinical trials. Int J Cardiol 2014; 177: 780–5.
5. Kyoung-Ha Park, Woo Jung Park, Min-Kyu Kim. Effects of Trimetazidine on Endothelial Dysfunction After Sheath Injury of Radial Artery 2010 Elsevier Inc. Am J Cardiol 2010; 105: 1723–7.
6. Jinsong Chen, Shanshan Zhou, Jing Jin. Chronic treatment with trimetazidine after discharge reduces the incidence of restenosis in patients who received coronary stent implantation: A 1-year prospective follow-up study. DOI: 10.3892/mmr.2016.5773
7. Glezer MG, Vygodin VA. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice. On behalf of ODA investigators. Adv Ther. https://doi.org/10.1007/s12325-018-0756-3//
8. Dedkova EN, Seidlmayer LK, Blatter LA. Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure. J Mol Cell Cardiol 2013. pii: S0022-2828(13)00054-0. DOI: 10.1016/j.yjmcc.2013.01.016
9. Belardinelli R, Solenghi M, Volpe L. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect. Online publish-ahead-of-print 24 April 2007.
10. Fragasso G, Rosano G, Baek SH. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study. Int J Cardiol 2012. http://dx.doi.org/10.1016/j.ijcard.2012.09.123
11. Dengfeng Gao, Ning Ning, Xiaolin Niu. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart 2011; 97: 278–86.
12. Lei Zhang, Yizhou Lu, Hong Jiang. Additional Use of Trimetazidine in Patients With Chronic Heart Failure A Meta-Analysis. J Am Col Cardiol 2012; 59 (10).
13. Xiaohan Xu, Weijun Zhang, Yujie Zhou. Effect of Trimetazidine on Recurrent Angina Pectoris and Left Ventricular Structure in Elderly Multivessel Coronary Heart Disease Patients with Diabetes Mellitus After Drug-Eluting Stent Implantation: A Single-Centre, Prospective, Randomized, Double-Blind Study at 2-Year Follow-Up. Springer International Publishing Switzerland 2014. Clin Drug Invest. DOI 10.1007/s40261-014-0170-9
________________________________________________
2. Jeong Su Kim, Chang Hoon Kim, Kook Jin Chun. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry. Clin Res Cardiol. DOI 10.1007/s00392-013-0611-0
3. Szwed H, Sadowski Z, Elikowski W. Combination treatment in stable effort angina using trimetazidine and metoprolol Results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J 2011; 22: 2267–74.
4. Song Peng, Min Zhao, Jing Wan. The efficacy of trimetazidine on stable angina pectoris: A meta-analysis of randomized clinical trials. Int J Cardiol 2014; 177: 780–5.
5. Kyoung-Ha Park, Woo Jung Park, Min-Kyu Kim. Effects of Trimetazidine on Endothelial Dysfunction After Sheath Injury of Radial Artery 2010 Elsevier Inc. Am J Cardiol 2010; 105: 1723–7.
6. Jinsong Chen, Shanshan Zhou, Jing Jin. Chronic treatment with trimetazidine after discharge reduces the incidence of restenosis in patients who received coronary stent implantation: A 1-year prospective follow-up study. DOI: 10.3892/mmr.2016.5773
7. Glezer MG, Vygodin VA. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice. On behalf of ODA investigators. Adv Ther. https://doi.org/10.1007/s12325-018-0756-3//
8. Dedkova EN, Seidlmayer LK, Blatter LA. Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure. J Mol Cell Cardiol 2013. pii: S0022-2828(13)00054-0. DOI: 10.1016/j.yjmcc.2013.01.016
9. Belardinelli R, Solenghi M, Volpe L. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect. Online publish-ahead-of-print 24 April 2007.
10. Fragasso G, Rosano G, Baek SH. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study. Int J Cardiol 2012. http://dx.doi.org/10.1016/j.ijcard.2012.09.123
11. Dengfeng Gao, Ning Ning, Xiaolin Niu. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart 2011; 97: 278–86.
12. Lei Zhang, Yizhou Lu, Hong Jiang. Additional Use of Trimetazidine in Patients With Chronic Heart Failure A Meta-Analysis. J Am Col Cardiol 2012; 59 (10).
13. Xiaohan Xu, Weijun Zhang, Yujie Zhou. Effect of Trimetazidine on Recurrent Angina Pectoris and Left Ventricular Structure in Elderly Multivessel Coronary Heart Disease Patients with Diabetes Mellitus After Drug-Eluting Stent Implantation: A Single-Centre, Prospective, Randomized, Double-Blind Study at 2-Year Follow-Up. Springer International Publishing Switzerland 2014. Clin Drug Invest. DOI 10.1007/s40261-014-0170-9
Авторы
Е.В.Акатова
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1
akev@list.ru
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И.Евдокимова» Минздрава России. 127473, Россия, Москва, ул. Делегатская, д. 20, стр. 1
akev@list.ru
________________________________________________
E.V.Akatova
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
akev@list.ru
A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation. 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
akev@list.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.
